These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9105409)
81. Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites. Elias L; Crissman HA Cancer Res; 1988 Sep; 48(17):4868-73. PubMed ID: 2457431 [TBL] [Abstract][Full Text] [Related]
82. Metabolism of 3'-azido-3'-deoxythymidine (AZT) in human placental trophoblasts and Hofbauer cells. Qian M; Bui T; Ho RJ; Unadkat JD Biochem Pharmacol; 1994 Jul; 48(2):383-9. PubMed ID: 8053935 [TBL] [Abstract][Full Text] [Related]
83. Recombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of application. Supersaxo A; Hein W; Gallati H; Steffen H Pharm Res; 1988 Aug; 5(8):472-6. PubMed ID: 3244653 [TBL] [Abstract][Full Text] [Related]
84. 3'-Azido-3'-deoxythymidine (AZT) inhibits thymidine phosphorylation in isolated rat liver mitochondria: a possible mechanism of AZT hepatotoxicity. Lynx MD; Bentley AT; McKee EE Biochem Pharmacol; 2006 Apr; 71(9):1342-8. PubMed ID: 16472780 [TBL] [Abstract][Full Text] [Related]
85. Divergent in vitro effects of recombinant interferons on human osteosarcoma cells. Harju VT; Alitalo R; Andersson LC Bone; 1990; 11(4):247-51. PubMed ID: 2122912 [TBL] [Abstract][Full Text] [Related]
86. Modulation of the cytotoxicity of 3'-azido-3'-deoxythymidine and methotrexate after transduction of folate receptor cDNA into human cervical carcinoma: identification of a correlation between folate receptor expression and thymidine kinase activity. Sun XL; Jayaram HN; Gharehbaghi K; Li QJ; Xiao X; Antony AC Cancer Res; 1999 Feb; 59(4):940-6. PubMed ID: 10029088 [TBL] [Abstract][Full Text] [Related]
87. 3'-Azido-3'-deoxythymidine inhibition of human lymphocyte cytolytic function in vitro. Shaw DR; Knight DR; Waterman AL; Sommadossi JP Biochem Pharmacol; 1991 Jan; 41(2):287-91. PubMed ID: 1989638 [TBL] [Abstract][Full Text] [Related]
88. Selective decrease in Leu8-negative T cell subpopulations following treatment with recombinant interferon-alpha 2a (rIFN-alpha 2a). MartÃnez-Maza O; Figlin RA; Giorgi JV; Fahey JL Cell Immunol; 1988 Nov; 117(1):89-98. PubMed ID: 2902935 [TBL] [Abstract][Full Text] [Related]
89. Inhibition of HIV-1 transmission by interferon and 3'-azido-3'-deoxythymidine during de novo infection of promonocytic cells. Dubreuil M; Sportza L; D'Addario M; Lacoste J; Rooke R; Wainberg MA; Hiscott J Virology; 1990 Nov; 179(1):388-94. PubMed ID: 1699354 [TBL] [Abstract][Full Text] [Related]
90. Effects of thymidine and uridine on the phosphorylation of 3'-azido-3'-deoxythymidine (zidovudine) in human mononuclear cells. Szebeni J; Patel SS; Hung K; Wahl LM; Weinstein JN Antimicrob Agents Chemother; 1991 Jan; 35(1):198-200. PubMed ID: 2014977 [TBL] [Abstract][Full Text] [Related]
91. Synergistic antiproliferative activity of suramin and alpha 2A-interferon against human colorectal adenocarcinoma cell lines: in vitro studies. Falcone A; Danesi R; Zaccaro L; Pieracci D; Pfanner E; Cianci C; Andreuccetti M; Malvaldi G; Del Tacca M; Conte PF Eur J Cancer; 1994; 30A(4):516-20. PubMed ID: 8018411 [TBL] [Abstract][Full Text] [Related]
92. Oxidative DNA damage induced by photodegradation products of 3(')-azido-3(')-deoxythymidine. Iwamoto T; Hiraku Y; Oikawa S; Mizutani H; Kojima M; Kawanishi S Arch Biochem Biophys; 2003 Aug; 416(2):155-63. PubMed ID: 12893292 [TBL] [Abstract][Full Text] [Related]
93. Long-term AZT exposure alters the metabolic capacity of cultured human lymphoblastoid cells. Olivero OA; Vazquez IL; Cooch CC; Ming J; Keller E; Yu M; Borojerdi JP; Braun HM; McKee E; Poirier MC Toxicol Sci; 2010 May; 115(1):109-17. PubMed ID: 20106944 [TBL] [Abstract][Full Text] [Related]
94. Recombinant IFN-alpha2b treatment activates poly (ADPR) polymerase-1 (PARP-1) in KB cancer cells. Quesada P; Malanga M; Di Meglio S; De Lorenzo S; Fabbrocini A; Garbi C; Bianco AR; Pepe S Eur J Cancer; 2003 Sep; 39(14):2103-9. PubMed ID: 12957467 [TBL] [Abstract][Full Text] [Related]
95. Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera. Foa P; Massaro P; Caldiera S; LaTargia ML; Iurlo A; Clerici C; Fornier M; Bertoni F; Maiolo AT Eur J Haematol; 1998 May; 60(5):273-7. PubMed ID: 9654155 [TBL] [Abstract][Full Text] [Related]
96. Effects of leukocyte interferon (E. coli) on human bone sarcoma growth in vitro and in the nude mouse. Hofmann V; Groscurth P; Morant R; Cserhati M; Honegger HP; von Hochstetter A Eur J Cancer Clin Oncol; 1985 Jul; 21(7):859-63. PubMed ID: 3862583 [TBL] [Abstract][Full Text] [Related]
97. Effect of AZT on thymidine phosphorylation in cultured H9c2, U-937, and Raji cell lines. Lynx MD; Kang BK; McKee EE Biochem Pharmacol; 2008 Apr; 75(8):1610-5. PubMed ID: 18295188 [TBL] [Abstract][Full Text] [Related]
98. Role of DNA Repair Pathways in Response to Zidovudine-induced DNA Damage in Immortalized Human Liver THLE2 Cells. Wu Q; Beland FA; Chang CW; Fang JL Int J Biomed Sci; 2013 Mar; 9(1):18-25. PubMed ID: 23675285 [TBL] [Abstract][Full Text] [Related]
99. Mechanisms of toxicity of 3'-azido-3'-deoxythymidine. Its interaction with adenylate kinase. Barile M; Valenti D; Hobbs GA; Abruzzese MF; Keilbaugh SA; Passarella S; Quagliariello E; Simpson MV Biochem Pharmacol; 1994 Oct; 48(7):1405-12. PubMed ID: 7945440 [TBL] [Abstract][Full Text] [Related]